SCN5A channelopathies - An update on mutations and mechanisms

Progress in Biophysics and Molecular Biology

Volumn 98, Issue 2-3, 2008, Pages 120-136

  Zimmer, Thomas ^a   Surber, Ralf ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Brugada syndrome; Cardiac conduction disease; LQT3; SCN5A

Indexed keywords

MUSCLE PROTEIN; SCN5A PROTEIN, HUMAN; SODIUM CHANNEL;

BRUGADA SYNDROME; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; ELECTROPHYSIOLOGY; GENETICS; GENOTYPE; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MUTATION; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; REVIEW;

ARRHYTHMIAS, CARDIAC; BRUGADA SYNDROME; ELECTROPHYSIOLOGICAL PHENOMENA; GENOTYPE; HUMANS; LONG QT SYNDROME; MODELS, MOLECULAR; MUSCLE PROTEINS; MUTATION; PHENOTYPE; SODIUM CHANNELS;

EID: 61849156873     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2008.10.005     Document Type: Review

References (196)

1. v1.5 by interacting proteins. Trends Cardiovasc. Med. 15 (2005) 35-40
2. + channel. Circ. Res. 88 (2001) 740-745
3. Ackerman M.J., Siu B.L., Sturner W.Q., Tester D.J., Valdivia C.R., Makielski J.C., and Towbin J.A. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286 (2001) 2264-2269
4. Ackerman M.J., Splawski I., Makielski J.C., Tester D.J., Will M.L., Timothy K.W., Keating M.T., Jones G., Chadha M., Burrow C.R., Stephens J.C., Xu C., Judson R., and Curran M.E. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1 (2004) 600-607
5. Akai J., Makita N., Sakurada H., Shirai N., Ueda K., Kitabatake A., Nakazawa K., Kimura A., and Hiraoka M. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett. 479 (2000) 29-34
6. Albert C.M., Nam E.G., Rimm E.B., Jin H.W., Hajjar R.J., Hunter D.J., MacRae C.A., and Ellinor P.T. Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation 117 (2008) 16-23
7. Alings M., and Wilde A. Brugada syndrome: clinical data and suggested pathophysiological mechanism. Circulation 99 (1999) 666-673
8. + channel does not affect ion selectivity properties. Acta Physiol. Scand. 185 (2005) 291-301
9. Antzelevitch C. Genetic basis of Brugada syndrome. Heart Rhythm 4 (2007) 756-757
10. Antzelevitch C., Pollevick G.D., Cordeiro J.M., Casis O., Sanguinetti M.C., Aizawa Y., Guerchicoff A., Pfeiffer R., Oliva A., Wollnik B., Gelber P., Bonaros Jr. E.P., Burashnikov E., Wu Y., Sargent J.D., Schickel S., Oberheiden R., Bhatia A., Hsu L.F., Haïssaguerre M., Schimpf R., Borggrefe M., and Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115 (2007) 442-449
11. Arnestad M., Crotti L., Rognum T.O., Insolia R., Pedrazzini M., Ferrandi C., Vege A., Wang D.W., Rhodes T.E., George Jr. A.L., and Schwartz P.J. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 115 (2007) 361-367
12. Bankston J.R., Yue M., Chung W., Spyres M., Pass R.H., Silver E., Sampson K.J., and Kass R.S. A novel and lethal de novo LQT-3 mutation in a newborn with distinct molecular pharmacology and therapeutic response. PLoS ONE 2 (2007) e1258
13. Baroudi G., and Chahine M. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes. FEBS Lett. 487 (2000) 224-228
14. Baroudi G., Pouliot V., Denjoy I., Guicheney P., Shrier A., and Chahine M. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circ. Res. 88 (2001) E78-E83
15. Baroudi G., Acharfi S., Larouche C., and Chahine M. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome. Circ. Res. 90 (2002) E11-E16
16. Baroudi G., Napolitano C., Priori S.G., Del Bufalo A., and Chahine M. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome. Can. J. Cardiol. 20 (2004) 425-430
17. Bébarová M., O'Hara T., Geelen J.L., Jongbloed R.J., Timmermans C., Arens Y.H., Rodriguez L.M., Rudy Y., and Volders P.G. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation. Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H48-H58
18. Benhorin J., Goldmit M., MacCluerm J.W., Blangero J., Goffen R., Leibovitch A., Rahat A., Wang Q., Medina A., Towbin J., and Kerem B. Identification of a new SCN5A mutation, D1840G, associated with the long QT syndrome. Mutations in brief no. 153. Online. Hum. Mutat. 12 (1998) 72
19. Bennett P.B., Yazawa K., Makita N., and George Jr. A.L. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376 (1995) 683-685
20. Benson D.W., Wang D.W., Dyment M., Knilans T.K., Fish F.A., Strieper M.J., Rhodes T.H., and George Jr. A.L. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112 (2003) 1019-1028
21. Berecki G., Zegers J.G., Bhuiyan Z.A., Verkerk A.O., Wilders R., and van Ginneken A.C. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique. J. Physiol. 570 (2006) 237-250
22. + channel mutation causing both long-QT and Brugada syndromes. Circ. Res. 85 (1999) 1206-1213
23. Bezzina C.R., Rook M.B., Groenewegen W.A., Herfst L.J., van der Wal A.C., Lam J., Jongsma H.J., Wilde A.A., and Mannens M.M. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ. Res. 92 (2003) 159-168
24. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 20 (1992) 1391-1396
25. Brugada P., Brugada R., and Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?. Circulation 112 (2005) 279-292
26. Camacho J.A., Hensellek S., Rougier J.S., Blechschmidt S., Abriel H., Benndorf K., and Zimmer T. Modulation of Nav1.5 channel function by an alternatively spliced sequence in the DII/DIII linker region. J. Biol. Chem. 281 (2006) 9498-9506
27. Casini S., Tan H.L., Bhuiyan Z.A., Bezzina C.R., Barnett P., Cerbai E., Mugelli A., Wilde A.A., and Veldkamp M.W. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Cardiovasc. Res. 76 (2007) 418-429
28. Catterall W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26 (2000) 13-25
29. Chanda B., and Bezanilla F. Tracking voltage-dependent conformational changes in skeletal muscle sodium channel during activation. J. Gen. Physiol. 120 (2002) 629-645
30. + channels expressed in mammalian cells. Am. J. Physiol. 274 (1998) H1643-H1654
31. Chang C.C., Acharfi S., Wu M.H., Chiang F.T., Wang J.K., Sung T.C., and Chahine M. A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia. Cardiovasc. Res. 64 (2004) 268-278
32. Chen L.Q., Santarelli V., Horn R., and Kallen R.G. A unique role for the S4 segment of domain 4 in the inactivation of sodium channels. J. Gen. Physiol. 108 (1996) 549-556
33. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., Potenza D., Moya A., Borggrefe M., Breithardt G., Ortiz-Lopez R., Wang Z., Antzelevitch C., O'Brien R.E., Schulze-Bahr E., Keating M.T., Towbin J.A., and Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
34. Chen T., Inoue M., and Sheets M.F. Reduced voltage dependence of inactivation in the SCN5A sodium channel mutation delF1617. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2666-H2676
35. Chung S.K., MacCormick J.M., McCulley C.H., Crawford J., Eddy C.A., Mitchell E.A., Shelling A.N., French J.K., Skinner J.R., and Rees M.I. Long QT and Brugada syndrome gene mutations in New Zealand. Heart Rhythm 4 (2007) 1306-1314
36. Clancy C.E., and Kass R.S. Defective cardiac ion channels: from mutations to clinical syndromes. J. Clin. Invest. 110 (2002) 1075-1077
37. Clancy C.E., and Rudy Y. Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature 400 (1999) 566-569
38. + channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 105 (2002) 1208-1213
39. + channels: an original mechanism of arrhythmia. Circulation 107 (2003) 2233-2237
40. Cordeiro J.M., Barajas-Martinez H., Hong K., Burashnikov E., Pfeiffer R., Orsino A.M., Wu Y.S., Hu D., Brugada J., Brugada P., Antzelevitch C., Dumaine R., and Brugada R. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation 114 (2006) 2026-2033
41. + channel C terminus: evidence for a role of helical structures in modulation of channel inactivation. J. Biol. Chem. 277 (2002) 9233-9241
42. Coronel R., Casini S., Koopmann T.T., Wilms-Schopman F.J., Verkerk A.O., de Groot J.R., Bhuiyan Z., Bezzina C.R., Veldkamp M.W., Linnenbank A.C., van der Wal A.C., Tan H.L., Brugada P., Wilde A.A., and de Bakker J.M. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112 (2005) 2769-2777
43. Darbar D., Kannankeril P.J., Donahue B.S., Kucera G., Stubblefield T., Haines J.L., George Jr. A.L., and Roden D.M. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 117 (2008) 1927-1935
44. Deschênes I., Baroudi G., Berthet M., Barde I., Chalvidan T., Denjoy I., Guicheney P., and Chahine M. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovasc. Res. 46 (2000) 55-65
45. Du R., Ren F.X., Yang J.G., Yuan G.H., Zhang S.Y., Kang C.L., Li W., Gui L., and Li J. Relationship between congenital long QT syndrome and Brugada syndrome gene mutation. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27 (2005) 289-294
46. + channel-linked long-QT syndrome. Circ. Res. 78 (1996) 916-924
47. Dumaine R., Towbin J.A., Brugada P., Vatta M., Nesterenko D.V., Nesterenko V.V., Brugada J., Brugada R., and Antzelevitch C. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ. Res. 85 (1999) 803-809
48. Ellinor P.T., Nam E.G., Shea M.A., Milan D.J., Ruskin J.N., and MacRae C.A. Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm 5 (2008) 99-105
49. Frigo G., Rampazzo A., Bauce B., Pilichou K., Beffagna G., Danieli G.A., Nava A., and Martini B. Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities. Europace 9 (2007) 391-397
50. Frustaci A., Priori S.G., Pieroni M., Chimenti C., Napolitano C., Rivolta I., Sanna T., Bellocci F., and Russo M.A. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112 (2005) 3680-3687
51. Gehi A.K., Duong T.D., Metz L.D., Gomes J.A., and Mehta D. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J. Cardiovasc. Electrophysiol. 17 (2006) 577-583
52. Gellens M.E., George Jr. A.L., Chen L.Q., Chahine M., Horn R., Barchi R.L., and Kallen R.G. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc. Natl. Acad. Sci. USA 89 (1992) 554-558
53. Glatter K.A., Wang Q., Keating M., Chen S., Chiamvimonvat N., and Scheinman M.M. Effectiveness of sotalol treatment in symptomatic Brugada syndrome. Am. J. Cardiol. 93 (2004) 1320-1322
54. Grant A.O., Carboni M.P., Neplioueva V., Starmer C.F., Memmi M., Napolitano C., and Priori S. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J. Clin. Invest. 110 (2002) 1201-1209
55. Groenewegen W.A., Firouzi M., Bezzina C.R., Vliex S., van Langen I.M., Sandkuijl L., Smits J.P., Hulsbeek M., Rook M.B., Jongsma H.J., and Wilde A.A. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ. Res. 92 (2003) 14-22
56. Haufe V., Chamberland C., and Dumaine R. The promiscuous nature of the cardiac sodium current. J. Mol. Cell. Cardiol. 42 (2007) 469-477
57. + channel mutation leading to loss of function and non-progressive cardiac conduction defects. J. Mol. Cell. Cardiol. 35 (2003) 549-557
58. Hong K., Berruezo-Sanchez A., Poungvarin N., Oliva A., Vatta M., Brugada J., Brugada P., Towbin J.A., Dumaine R., Piñero-Galvez C., Antzelevitch C., and Brugada R. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A. J. Cardiovasc. Electrophysiol. 15 (2004) 64-69
59. Hong K., Guerchicoff A., Pollevick G.D., Oliva A., Dumaine R., de Zutter M., Burashnikov E., Wu Y.S., Brugada J., Brugada P., and Brugada R. Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. J. Mol. Cell. Cardiol. 38 (2005) 555-560
60. v1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes. Can. J. Cardiol. 22 (2006) 309-313
61. Hwang H.W., Chen J.J., Lin Y.J., Shieh R.C., Lee M.T., Hung S.I., Wu J.Y., Chen Y.T., Niu D.M., and Hwang B.T. R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J. Med. Genet. 42 (2005) e7
62. Itoh H., Shimizu M., Mabuchi H., and Imoto K. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A. J. Cardiovasc. Electrophysiol. 16 (2005) 378-383
63. Itoh H., Shimizu M., Takata S., Mabuchi H., and Imoto K. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs. J. Cardiovasc. Electrophysiol. 16 (2005) 486-493
64. Juang J.M., Huang S.K., Tsai C.T., Chiang F.T., Lin J.L., Lai L.P., Wang C.C., Kuo C.T., Ueng K.C., Kong C.W., Ko W.C., Lei M.H., and Tsao H.M. Characteristics of Chinese patients with symptomatic Brugada syndrome in Taiwan. Cardiology 99 (2003) 182-189
65. Junttila M.J., Gonzalez M., Lizotte E., Benito B., Vernooy K., Sarkozy A., Huikuri H.V., Brugada P., Brugada J., and Brugada R. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 117 (2008) 1890-1893
66. Kambouris N.G., Nuss H.B., Johns D.C., Tomaselli G.F., Marban E., and Balser J.R. Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel. Circulation 97 (1998) 640-644
67. Kehl H.G., Haverkamp W., Rellensmann G., Yelbuz T.M., Krasemann T., Vogt J., and Schulze-Bahr E. Images in cardiovascular medicine. Life-threatening neonatal arrhythmia: successful treatment and confirmation of clinically suspected extreme long QT-syndrome-3. Circulation 109 (2004) e205-e206
68. + channels. J. Gen. Physiol. 109 (1997) 607-617
69. Keller D.I., Acharfi S., Delacrétaz E., Benammar N., Rotter M., Pfammatter J.P., Fressart V., Guicheney P., and Chahine M. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation. J. Mol. Cell. Cardiol. 35 (2003) 1513-1521
70. Keller D.I., Rougier J.S., Kucera J.P., Benammar N., Fressart V., Guicheney P., Madle A., Fromer M., Schläpfer J., and Abriel H. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovasc. Res. 67 (2005) 510-519
71. Keller D.I., Barrane F.Z., Gouas L., Martin J., Pilote S., Suarez V., Osswald S., Brink M., Guicheney P., Schwick N., and Chahine M. A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state. Can. J. Cardiol. 21 (2005) 925-931
72. Keller D.I., Huang H., Zhao J., Frank R., Suarez V., Delacrétaz E., Brink M., Osswald S., Schwick N., and Chahine M. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Cardiovasc. Res. 70 (2006) 521-529
73. 2+ sensitivity of sodium channels. J. Biol. Chem. 279 (2004) 45004-45012
74. Kranjcec D., Bergovec M., Rougier J.S., Raguz M., Pavlovic S., Jespersen T., Castella V., Keller D.I., and Abriel H. Brugada syndrome unmasked by accidental inhalation of gasoline vapors. Pacing Clin. Electrophysiol. 30 (2007) 1294-1298
75. Kyndt F., Probst V., Potet F., Demolombe S., Chevallier J.C., Baro I., Moisan J.P., Boisseau P., Schott J.J., Escande D., and Le Marec H. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 104 (2001) 3081-3086
76. Lai L.P., Su Y.N., Hsieh F.J., Chiang F.T., Juang J.M., Liu B., Ho Y.L., Chen W.J., Yeh S.J., Wang C.C., Ko Y.L., Wu T.J., Ueng K.C., Lei M.H., Tsao H.M., Chen S.A., Lin T.K., Wu M.H., Lo H.M., Huang S.K., and Lin J.L. Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms. J. Hum. Genet. 50 (2005) 490-496
77. Levy-Nissenbaum E., Eldar M., Wang Q., Lahat H., Belhassen B., Ries L., Friedman E., and Pras E. Genetic analysis of Brugada syndrome in Israel: two novel mutations and possible genetic heterogeneity. Genet. Test. 5 (2001) 331-334
78. Liang P., Liu W.L., Hu D.Y., Li C.L., Tao W.H., and Li L. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I. A1649V and delF1617] Zhonghua Xin Xue Guan Bing Za Zhi 34 (2006) 616-619
79. Liu K., Yang T., Viswanathan P.C., and Roden D.M. New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant. Circulation 112 (2005) 3239-3246
80. + current and causes inherited arrhythmias. Circulation 116 (2007) 2260-2268
81. Lupoglazoff J.M., Cheav T., Baroudi G., Berthet M., Denjoy I., Cauchemez B., Extramiana F., Chahine M., and Guicheney P. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ. Res. 89 (2001) E16-E21
82. Makielski J.C., Ye B., Valdivia C.R., Pagel M.D., Pu J., Tester D.J., and Ackerman M.J. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ. Res. 93 (2003) 821-828
83. + channel exhibiting novel molecular mechanisms of long QT syndrome. FEBS Lett. 423 (1998) 5-9
84. Makita N., Horie M., Nakamura T., Ai T., Sasaki K., Yokoi H., Sakurai M., Sakuma I., Otani H., Sawa H., and Kitabatake A. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation 106 (2002) 1269-1274
85. Makita N., Sasaki K., Groenewegen W.A., Yokota T., Yokoshiki H., Murakami T., and Tsutsui H. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2 (2005) 1128-1134
86. Makita N., Sumitomo N., Watanabe I., and Tsutsui H. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope. Heart Rhythm 4 (2007) 516-519
87. Makita N., Behr E., Shimizu W., Horie M., Sunami A., Crotti L., Schulze-Bahr E., Fukuhara S., Mochizuki N., Makiyama T., Itoh H., Christiansen M., McKeown P., Miyamoto K., Kamakura S., Tsutsui H., Schwartz P.J., George Jr. A.L., and Roden D.M. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J. Clin. Invest. 118 (2008) 2219-2229
88. Makita N., Mochizuki N., and Tsutsui H. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome. Circ. J. 72 (2008) 1018-1019
89. Makiyama T., Akao M., Tsuji K., Doi T., Ohno S., Takenaka K., Kobori A., Ninomiya T., Yoshida H., Takano M., Makita N., Yanagisawa F., Higashi Y., Takeyama Y., Kita T., and Horie M. High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J. Am. Coll. Cardiol. 46 (2005) 2100-2106
90. Márquez M.F., Cruz-Robles D., Inés-Real S., Gallardo G.J., Gonzlez-Hermosillo A., Cárdenas M., and Vargas-Alarcón G. A novel SCN5A deletion mutation in a child with ventricular tachycardia, recurrent aborted sudden death, and Brugada electrocardiographic pattern. Arch. Cardiol. Mex. 77 (2007) 284-287
91. McPhee J.C., Ragsdale D.S., Scheuer T., and Catterall W.A. A critical role for the S4-S5 intracellular loop in domain IV of the sodium channel alpha-subunit in fast inactivation. J. Biol. Chem. 273 (1998) 1121-1129
92. Meregalli P.G., Wilde A.A., and Tan H.L. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc. Res. 67 (2005) 367-378
93. Millat G., Chevalier P., Restier-Miron L., Da Costa A., Bouvagnet P., Kugener B., Fayol L., Gonzàlez Armengod C., Oddou B., Chanavat V., Froidefond E., Perraudin R., Rousson R., and Rodriguez-Lafrasse C. Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin. Genet. 70 (2006) 214-227
94. Mohler P.J., Rivolta I., Napolitano C., LeMaillet G., Lambert S., Priori S.G., and Bennett V. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc. Natl. Acad. Sci. USA 101 (2004) 17533-17538
95. Mok N.S., Priori S.G., Napolitano C., Chan N.Y., Chahine M., and Baroudi G. A newly characterized SCN5A mutation underlying Brugada syndrome unmasked by hyperthermia. J. Cardiovasc. Electrophysiol. 14 (2003) 407-411
96. Mok N.S., Priori S.G., Napolitano C., Chan K.K., Bloise R., Chan H.W., Fung W.H., Chan Y.S., Chan W.K., Lam C., Chan N.Y., and Tsang H.H. Clinical profile and genetic basis of Brugada syndrome in the Chinese population. Hong Kong Med. J. 10 (2004) 32-37
97. + channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J. Gen. Physiol. 123 (2004) 155-165
98. Nademanee K., Veerakul G., Nimmannit S., Chaowakul V., Bhuripanyo K., Likittanasombat K., Tunsanga K., Kuasirikul S., Malasit P., Tansupasawadikul S., and Tatsanavivat P. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 96 (1997) 2595-2600
99. + channels. Am. J. Physiol. Heart Circ. Physiol. 44 (1998) H2016-H2024
100. Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E., Nastoli J., Bottelli G., Cerrone M., and Leonardi S. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 294 (2005) 2975-2980
101. Niimura H., Matsunaga A., Kumagai K., Ohwaki K., Ogawa M., Noguchi H., Yonemura K., and Saku K. Genetic analysis of Brugada syndrome in Western Japan: two novel mutations. Circ. J. 68 (2004) 740-746
102. Niu D.M., Hwang B., Hwang H.W., Wang N.H., Wu J.Y., Lee P.C., Chien J.C., Shieh R.C., and Chen Y.T. A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect. J. Med. Genet. 43 (2006) 817-821
103. Nuyens D., Stengl M., Dugarmaa S., Rossenbacker T., Compernolle V., Rudy Y., Smits J.F., Flameng W., Clancy C.E., Moons L., Vos M.A., Dewerchin M., Benndorf K., Collen D., Carmeliet E., and Carmeliet P. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat. Med. 7 (2001) 1021-1027
104. Onkal R., Mattis J.H., Fraser S.P., Diss J.K., Shao D., Okuse K., and Djamgoz M.B. Alternative splicing of Nav1.5: an electrophysiological comparison of 'neonatal' and 'adult' isoforms and critical involvement of a lysine residue. J. Cell. Physiol. 216 (2008) 716-726
105. Oliva A., Bjerregaard P., Hong K., Evans S., Vernooy K., McCormack J., Brugada J., Brugada P., Pascali V.L., and Brugada R. Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation?. Cardiology 110 (2008) 116-122
106. Olson T.M., Michels V.V., Ballew J.D., Reyna S.P., Karst M.L., Herron K.J., Horton S.C., Rodeheffer R.J., and Anderson J.L. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293 (2005) 447-454
107. Otagiri T., Kijima K., Osawa M., Ishii K., Makita N., Matoba R., Umetsu K., and Hayasaka K. Cardiac Ion Channel Gene Mutations in Sudden Infant Death Syndrome. Pediatr. Res. (2008) [Epub ahead of print]
108. Petitprez S., Jespersen T., Pruvot E., Keller D.I., Corbaz C., Schläpfer J., Abriel H., and Kucera J.P. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome. Cardiovasc. Res. 78 (2008) 494-504
109. Pfahnl A.E., Viswanathan P.C., Weiss R., Shang L.L., Sanyal S., Shusterman V., Kornblit C., London B., and Dudley Jr. S.C. A sodium channel pore mutation causing Brugada syndrome. Heart Rhythm 4 (2007) 46-53
110. Potet F., Mabo P., Le Coq G., Probst V., Schott J.J., Airaud F., Guihard G., Daubert J.C., Escande D., and Le Marec H. Novel Brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads. J. Cardiovasc. Electrophysiol. 14 (2003) 200-203
111. Priori S.G., and Napolitano C. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?. Circulation 112 (2005) 279-292
112. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della Bella P., Brignole M., Giordano U., Giovannini T., Menozzi C., Bloise R., Crotti L., Terreni L., and Schwartz P.J. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 102 (2000) 2509-2515
113. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della Bella P., Giordano U., Bloise R., Giustetto C., De Nardis R., Grillo M., Ronchetti E., Faggiano G., and Nastoli J. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105 (2002) 1342-1347
114. Priori S.G., Schwartz P.J., Napolitano C., Bloise R., Ronchetti E., Grillo M., Vicentini A., Spazzolini C., Nastoli J., Bottelli G., Folli R., and Cappelletti D. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348 (2003) 1866-1874
115. Priori S.G., Napolitano C., Schwartz P.J., Grillo M., Bloise R., Ronchetti E., Moncalvo C., Tulipani C., Veia A., Bottelli G., and Nastoli J. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292 (2004) 1341-1344
116. Priori S.G., Napolitano C., and Gasparini M. Letter regarding article by Coronel, et al, "right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study". Circulation 113 (2006) e726 author reply 726-727
117. Probst V., Kyndt F., Potet F., Trochu J.N., Mialet G., Demolombe S., Schott J.J., Baró I., Escande D., and Le Marec H. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. J. Am. Coll. Cardiol. 41 (2003) 643-652
118. Probst V., Allouis M., Sacher F., Pattier S., Babuty D., Mabo P., Mansourati J., Victor J., Nguyen J.M., Schott J.J., Boisseau P., Escande D., and Le Marec H. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J. Cardiovasc. Electrophysiol. 17 (2006) 270-275
119. Remme C.A., Verkerk A.O., Nuyens D., van Ginneken A.C., van Brunschot S., Belterman C.N., Wilders R., van Roon M.A., Tan H.L., Wilde A.A., Carmeliet P., de Bakker J.M., Veldkamp M.W., and Bezzina C.R. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 24 (2006) 2584-2594
120. Rivolta I., Abriel H., Tateyama M., Liu H., Memmi M., Vardas P., Napolitano C., Priori S.G., and Kass R.S. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J. Biol. Chem. 276 (2001) 30623-30630
121. Rivolta I., Clancy C.E., Tateyama M., Liu H., Priori S.G., and Kass R.S. A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction. Physiol. Genomics 10 (2002) 191-197
122. Rook M.B., BezzinaAlshinawi C., Groenewegen W.A., van Gelder I.C., van Ginneken A.C., Jongsma H.J., Mannens M.M., and Wilde A.A. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc. Res. 44 (1999) 507-517
123. Rossenbacker T., Schollen E., Kuipéri C., de Ravel T.J., Devriendt K., Matthijs G., Collen D., Heidbüchel H., and Carmeliet P. Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy. J. Med. Genet. 42 (2005) e29
124. Ruan Y., Liu N., Bloise R., Napolitano C., and Priori S.G. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients. Circulation 116 (2007) 1137-1144
125. Schott J.J., Alshinawim C., Kyndt F., Probst V., Hoorntje T.M., Hulsbeek M., Wilde A.A., Escande D., Mannens M.M., and Le Marec H. Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet. 23 (1999) 20-21
126. Schulze-Bahr E., Eckardt L., Breithardt G., Seidl K., Wichter T., Wolpert C., Borggrefe M., and Haverkamp W. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum. Mutat. 21 (2003) 651-652
127. Schwartz P.J., Priori S.G., Dumaine R., Napolitano C., Antzelevitch C., Stramba-Badiale M., Richard T.A., Berti M.R., and Bloise R. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N. Engl. J. Med. 343 (2000) 262-267
128. Schwartz P.J., Priori S.G., Spazzolini C., Moss A.J., Vincent G.M., Napolitano C., Denjoy I., Guicheney P., Breithardt G., Keating M.T., Towbin J.A., Beggs A.H., Brink P., Wilde A.A., Toivonen L., Zareba W., Robinson J.L., Timothy K.W., Corfield V., Wattanasirichaigoon D., Corbett C., Haverkamp W., Schulze-Bahr E., Lehmann M.H., Schwartz K., Coumel P., and Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
129. Schwartz P.J., Priori S.G., and Napolitano C. How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome. J. Cardiovasc. Electrophysiol. 14 (2003) 1120-1121
130. Sheets M.F., and Hanck D.A. Voltage-dependent open-state inactivation of cardiac sodium channels: gating current studies with Anthopleurin-A toxin. J. Gen. Physiol. 106 (1995) 617-640
131. Sheets M.F., Kyle J.W., Kallen R.G., and Hanck D.A. The Na channel voltage sensor associated with inactivation is localized to the external charged residues of domain IV, S4. Biophys. J. 77 (1999) 747-757
132. Shin D.J., Jang Y., Park H.Y., Lee J.E., Yang K., Kim E., Bae Y., Kim J., Kim J., Kim S.S., Lee M.H., Chahine M., and Yoon S.K. Genetic analysis of the cardiac sodium channel gene SCN5A in Koreans with Brugada syndrome. J. Hum. Genet. 49 (2004) 573-578
133. Shin D.J., Kim E., Park S.B., Jang W.C., Bae Y., Han J., Jang Y., Joung B., Lee M.H., Kim S.S., Huang H., Chahine M., and Yoon S.K. A novel mutation in the SCN5A gene is associated with Brugada syndrome. Life Sci. 80 (2007) 716-724
134. Shirai N., Makita N., Sasaki K., Yokoi H., Sakuma I., Sakurada H., Akai J., Kimura A., Hiraoka M., and Kitabatake A. A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease. Cardiovasc. Res. 53 (2002) 348-354
135. Six I., Hermida J.S., Huang H., Gouas L., Fressart V., Benammar N., Hainque B., Denjoy I., Chahine M., and Guicheney P. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Europace 10 (2008) 79-85
136. Skinner J.R., Chung S.K., Nel C.A., Shelling A.N., Crawford J.R., McKenzie N., Pinnock R., French J.K., and Rees M.I. Brugada syndrome masquerading as febrile seizures. Pediatrics 119 (2007) e1206-e1211
137. Smith M.R., and Goldin A.L. Interaction between the sodium channel inactivation linker and domain III S4-S5. Biophys. J. 73 (1997) 1885-1895
138. Smits J.P., Eckardt L., Probst V., Bezzina C.R., Schott J.J., Remme C.A., Haverkamp W., Breithardt G., Escande D., Schulze-Bahr E., LeMarec H., and Wilde A.A.M. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J. Am. Coll. Cardiol. 40 (2002) 350-356
139. Smits J.P., Veldkamp M.W., Bezzina C.R., Bhuiyan Z.A., Wedekind H., Schulze-Bahr E., and Wilde A.A. Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome. Cardiovasc. Res. 67 (2005) 459-466
140. Smits J.P., Koopmann T.T., Wilders R., Veldkamp M.W., Opthof T., Bhuiyan Z.A., Mannens M.M., Balser J.R., Tan H.L., Bezzina C.R., and Wilde A.A. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J. Mol. Cell. Cardiol. 38 (2005) 969-981
141. Smits J.P., Veldkamp M.W., and Wilde A.A. Mechanisms of inherited cardiac conduction disease. Europace 7 (2005) 122-137
142. Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S., Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M., and Keating M.T. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102 (2000) 1178-1185
143. Surber R., Hensellek S., Prochnau D., Werner G.S., Benndorf K., Figulla H.R., and Zimmer T. Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel. Cardiovasc. Res. 77 (2008) 740-748
144. Takahata T., Yasui-Furukori N., Sasaki S., Igarashi T., Okumura K., Munakata A., and Tateishi T. Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects. Life Sci. 72 (2003) 2391-2399
145. Tan B.H., Valdivia C.R., Rok B.A., Ye B., Ruwaldt K.M., Tester D.J., Ackerman M.J., and Makielski J.C. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2 (2005) 741-747
146. Tan B.H., Valdivia C.R., Song C., and Makielski J.C. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am. J. Physiol. Heart. Circ. Physiol. 291 (2006) H1822-H1828
147. Tan H.L. Sodium channel variants in heart disease: expanding horizons. J. Cardiovasc. Electrophysiol. 17 Suppl. 1 (2006) S151-S157
148. Tan H.L., Bink-Boelkens M.T., Bezzina C.R., Viswanathan P.C., Beaufort-Krol G.C., van Tintelen P.J., van den Berg M.P., Wilde A.A., and Balser J.R. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 409 (2001) 1043-1047
149. Tan H.L., Kupershmidt S., Zhang R., Stepanovic S., Roden D.M., Wilde A.A., Anderson M.E., and Balser J.R. A calcium sensor in the sodium channel modulates cardiac excitability. Nature 415 (2002) 442-447
150. Tang L., Chehab N., Wieland S.J., and Kallen R.G. Glutamine substitution at alanine1649 in the S4-S5 cytoplasmic loop of domain 4 removes the voltage sensitivity of fast inactivation in the human heart sodium channel. J. Gen. Physiol. 111 (1998) 639-652
151. Tateyama M., Kurokawa J., Terrenoire C., Rivolta I., and Kass R.S. Stimulation of protein kinase C inhibits bursting in disease-linked mutant human cardiac sodium channels. Circulation 107 (2003) 3216-3222
152. Tateyama M., Rivolta I., Clancy C.E., and Kass R.S. Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation. J. Biol. Chem. 278 (2003) 46718-46726
153. Tester D.J., Will M.L., Haglund C.M., and Ackerman M.J. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2 (2005) 507-517
154. Tian X.L., Yong S.L., Wan X., Wu L., Chung M.K., Tchou P.J., Rosenbaum D.S., Van Wagoner D.R., Kirsch G.E., and Wang Q. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. Cardiovasc. Res. 61 (2004) 256-267
155. Tian X.L., Cheng Y., Zhang T., Liao M.L., Yong S.L., and Wang Q.K. Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S. Biochem. Biophys. Res. Commun. 352 (2007) 879-883
156. Tian L., Zhu J.F., and Yang J.G. Gene (SCN5A) mutation analysis of a Chinese family with Brugada syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 35 (2007) 1122-1125
157. Valdivia C.R., Ackerman M.J., Tester D.J., Wada T., McCormack J., Ye B., and Makielski J.C. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine. Cardiovasc. Res. 55 (2002) 279-289
158. Valdivia C.R., Tester D.J., Rok B.A., Porter C.B., Munger T.M., Jahangir A., Makielski J.C., and Ackerman M.J. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs. Cardiovasc. Res. 62 (2004) 53-62
159. Van Langen I.M., Birnie E., Alders M., Jongbloed R.J., Le Marec H., and Wilde A.A. The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J. Med. Genet. 40 (2003) 141-145
160. Van Norstrand D.W., Valdivia C.R., Tester D.J., Ueda K., London B., Makielski J.C., and Ackerman M.J. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 116 (2007) 2253-2259
161. Vatta M., Dumaine R., Antzelevitch C., Brugada R., Li H., Bowles N.E., Nademanee K., Brugada J., Brugada P., and Towbin J.A. Novel mutations in domain I of SCN5A cause Brugada syndrome. Mol. Genet. Metab. 75 (2002) 317-324
162. Vatta M., Dumaine R., Varghese G., Richard T.A., Shimizu W., Aihara N., Nademanee K., Brugada R., Brugada J., Veerakul G., Li H., Bowles N.E., Brugada P., Antzelevitch C., and Towbin J.A. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum. Mol. Genet. 11 (2002) 337-345
163. + channel. Circ. Res. 86 (2000) E91-E97
164. Vilin Y.Y., Fujimoto E., and Ruben P.C. A novel mechanism associated with idiopathic ventricular fibrillation (IVF) mutations R1232W and T1620M in human cardiac sodium channels. Pflugers Arch. 442 (2001) 204-211
165. Viswanathan P.C., Benson D.W., and Balser J.R. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J. Clin. Invest. 111 (2003) 341-346
166. Viswanathan P.C., and Balser J.R. Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc. Med. 14 (2004) 28-35
167. Vorobiof G., Kroening D., Hall B., Brugada R., and Huang D. Brugada syndrome with marked conduction disease: dual implications of a SCN5A mutation. Pacing Clin. Electrophysiol. 31 (2008) 630-634
168. + channel associated with idiopathic ventricular fibrillation. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H354-H360
169. + channel mutations in the congenital long QT syndrome. Proc. Natl. Acad. Sci. USA 93 (1996) 13200-13205
170. + channel intermediate inactivation in Brugada syndrome. Circ. Res. 87 (2000) E37-E43
171. Wang D.W., Viswanathan P.C., Balser J.R., George Jr. A.L., and Benson D.W. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 105 (2002) 341-346
172. Wang D.W., Desai R.R., Crotti L., Arnestad M., Insolia R., Pedrazzini M., Ferrandi C., Vege A., Rognum T., Schwartz P.J., and George Jr. A.L. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 115 (2007) 368-376
173. Wang Q., Chen S., Chen Q., Wan X., Shen J., Hoeltge G.A., Timur A.A., Keating M.T., and Kirsch G.E. The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J. Med. Genet. 41 (2004) e66
174. Watanabe H., Koopmann T.T., Le Scouarnec S., Yang T., Ingram C.R., Schott J.J., Demolombe S., Probst V., Anselme F., Escande D., Wiesfeld A.C., Pfeufer A., Kääb S., Wichmann H.E., Hasdemir C., Aizawa Y., Wilde A.A., Roden D.M., and Bezzina C.R. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 118 (2008) 2260-2268
175. Wattanasirichaigoon D., Vesely M.R., Duggal P., Levine J.C., Blume E.D., Wolff G.S., Edwards S.B., and Beggs A.H. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations. Am. J. Med. Genet. 86 (1999) 470-476
176. Wedekind H., Smits J.P., Schulze-Bahr E., Arnold R., Veldkamp M.W., Bajanowski T., Borggrefe M., Brinkmann B., Warnecke I., Funke H., Bhuiyan Z.A., Wilde A.A., Breithardt G., and Haverkamp W. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 104 (2001) 1158-1164
177. + channel alpha-subunit: a computational analysis. Circulation 102 (2000) 584-590
178. + channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating. Hum. Mutat. 21 (2003) 552
179. + channel. Circulation 99 (1999) 3165-3171
180. +-channel inactivation. Proc. Natl. Acad. Sci. USA 89 (1992) 10910-10914
181. Wilde A.A., and Tan H.L. Relation between basic and clinical electrophysiologic characteristics in Brugada syndrome: facts or fiction?. J. Cardiovasc. Electrophysiol. 14 (2003) 412-414
182. Wu L., Archacki S.R., Zhang T., and Wang Q.K. Induction of high STAT1 expression in transgenic mice with LQTS and heart failure. Biochem. Biophys. Res. Commun. 358 (2007) 449-454
183. + current kinetics. Biochem. Biophys. Res. Commun. 281 (2001) 45-52
184. + channels. Proc. Natl. Acad. Sci. USA 98 (2001) 3606-3611
185. Yan G.X., and Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100 (1999) 1660-1666
186. Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C., Hohnloser S.H., Shimizu W., Schwartz P.J., Stanton M., Murray K.T., Norris K., George Jr. A.L., and Roden D.M. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105 (2002) 1943-1948
187. Yang P., Koopmann T.T., Pfeufer A., Jalilzadeh S., Schulze-Bahr E., Kääb S., Wilde A.A., Roden D.M., and Bezzina C.R. Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity. Eur. J. Hum. Genet. 16 (2008) 350-357
188. Ye B., Valdiviam C., R,Ackerman M.J., and Makielski J.C. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol. Genomics. 12 (2003) 187-193
189. Yi S.D., Meng S.R., Cui Y.K., Chen Z.M., and Peng J. PCR-based site-directed mutagenesis and recombinant expression plasmid construction of a SCN5A mutation (K317N) identified in a Chinese family with Brugada syndrome. Di Yi Jun Yi Da Xue Xue Bao 23 (2003) 1139-1142
190. Yokoi H., Makita N., Sasaki K., Takagi Y., Okumura Y., Nishino T., Makiyama T., Kitabatake A., Horie M., Watanabe I., and Tsutsui H. Double SCN5A mutation underlying asymptomatic Brugada syndrome. Heart Rhythm 2 (2005) 285-292
191. Yokokawa M., Noda T., Okamura H., Satomi K., Suyama K., Kurita T., Aihara N., Kamakura S., and Shimizu W. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am. J. Cardiol. 100 (2007) 649-655
192. Yong S.L., Ni Y., Zhang T., Tester D.J., Ackerman M.J., and Wang Q.K. Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes. Biochem. Biophys. Res. Commun. 352 (2007) 378-383
193. Zhang Z.S., Tranquillo J., Neplioueva V., Bursac N., and Grant A.O. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease. Am. J. Physiol. Heart. Circ. Physiol. 292 (2007) H399-H407
194. Zhang Y., Wang T., Ma A., Zhou X., Gui J., Wan H., Shi R., Huang C., Grace A.A., Huang C.L., Trump D., Zhang H., Zimmer T., and Lei M. Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel. Acta Physiol. 194 (2008) 311-323
195. + channels: primary structure and function of two isoforms and alternatively spliced variants. Am. J. Physiol. Heart. Circ. Physiol. 282 (2002) H1007-H1017
196. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., Klein G., Moss A.J., Myerburg R.J., Priori S.G., Quinones M.A., Roden D.M., Silka M.J., Tracy C., Smith Jr. S.C., Jacobs A.K., Adams C.D., Antman E.M., Anderson J.L., Hunt S.A., Halperin J.L., Nishimura R., Ornato J.P., Page R.L., Riegel B., Blanc J.J., Budaj A., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J.L., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 114 (2006) e385-e484